Drawing for PGI PSYCHOGENICS TRANSFORMING CNS DISCOVERY

USPTO serial 98862767

PGI PSYCHOGENICS TRANSFORMING CNS DISCOVERY

Reviewed by CopyMark Law Group

Reg. 8140686Status 700Registered
Filing date
Status date
Registration date
Feb 17, 2026
Examiner
DWYER, JOHN D
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PGI PSYCHOGENICS TRANSFORMING CNS DISCOVERY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lynn E. Rzonca

1735 Market Street, 51st FloorPhiladelphia, PA 19103United States

Goods and services

ClassDescriptionStatusFirst use
042Medical and scientific research in the field of behavioral, analgesic, psychiatric, neuroprotective, circadian, cognitive and motor capacities on normal, mutated, drug-treated or aged animals; medical research testing in the field of preclinical research; medical research testing in the field of drug discovery research; medical research testing in the field of central nervous system research; pharmacological phenotype testing in the field of drug discovery and medical research; scientific research and development services in the field of drug discovery, psychiatry, and the central nervous system, utilizing apparatus for measuring and accessing motor responses on normal, drug-treated or aged animals; medical and scientific research, namely, pharmaceutical and biotechnological research of human disorders using animal models, specifically, screening and testing of chemical compounds for therapeutic or toxic effects, and capturing, quantifying, processing and electronic data storage of information on behavioral and physiological changes in animal subjectsACTIVENov 11, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 17, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 17, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 30, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 30, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 24, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 3, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 3, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Dec 3, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 3, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 3, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 14, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 14, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 14, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 20, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 20, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 20, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 20, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 14, 2025DOCKASSIGNED TO EXAMINER—
May 11, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 20, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance